MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

Aims. Inhibitors of the MET pathway hold promise in the treatment for metastatic kidney cancer. Assessment of predictive biomarkers may be necessary for appropriate patient selection. Understanding MET expression in metastases and the correlation to the primary site is important, as distant tissue i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuch, Brian, Falbo, Ryan, Parisi, Fabio, Adeniran, Adebowale, Kluger, Yuval, Kluger, Harriet M., Jilaveanu, Lucia B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584049/
https://www.ncbi.nlm.nih.gov/pubmed/26448928
http://dx.doi.org/10.1155/2015/192406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584049/
https://www.ncbi.nlm.nih.gov/pubmed/26448928
http://dx.doi.org/10.1155/2015/192406

Ejemplares similares